Patent · US Active

Reactive polysaccharide-based hemostatic agent

US11739166B2 · kind B2 · utility

1Cited by
239References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2021
Grant dateAug 29, 2023
Priority date
Expiry dateJul 1, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/40
  • WIPO fieldMacromolecular chemistry, polymers
  • WIPO sectorChemistry

Abstract

Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.